ArticleJournal of thrombosis and thrombolysis2020

Monitoring the roles of prothrombin activation fragment 1 and 2 (F1 + 2) in patients with atrial fibrillation receiving rivaroxaban and apixaban.

Ei-Ichi Ueno et al.PubMed ↗Publisher ↗

No numbers read from the abstract.